Jonathan Miller
Stock Analyst at Evercore ISI Group
(0.64)
# 4,097
Out of 5,163 analysts
10
Total ratings
44.44%
Success rate
-20.55%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jonathan Miller
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZYME Zymeworks | Maintains: Outperform | $33 → $48 | $22.88 | +109.79% | 1 | Mar 9, 2026 | |
| CRBU Caribou Biosciences | Maintains: Outperform | $11 → $13 | $1.88 | +591.49% | 1 | Mar 9, 2026 | |
| AVIR Atea Pharmaceuticals | Maintains: Outperform | $6 → $10 | $6.10 | +63.93% | 1 | Mar 9, 2026 | |
| ARVN Arvinas | Maintains: Outperform | $14 → $19 | $12.18 | +55.99% | 1 | Feb 25, 2026 | |
| AURA Aura Biosciences | Reinstates: Outperform | $13 | $5.94 | +118.86% | 1 | Nov 26, 2025 | |
| NTLA Intellia Therapeutics | Downgrades: In-Line | $17 → $8 | $12.76 | -37.30% | 1 | Nov 11, 2025 | |
| PROK ProKidney | Initiates: Outperform | n/a | $2.25 | - | 1 | Sep 2, 2022 | |
| TRDA Entrada Therapeutics | Initiates: Outperform | n/a | $12.69 | - | 1 | Nov 24, 2021 | |
| STTK Shattuck Labs | Initiates: Outperform | n/a | $5.99 | - | 1 | Jan 11, 2021 | |
| NBTX Nanobiotix | Initiates: Outperform | n/a | $33.07 | - | 1 | Jan 6, 2021 |
Zymeworks
Mar 9, 2026
Maintains: Outperform
Price Target: $33 → $48
Current: $22.88
Upside: +109.79%
Caribou Biosciences
Mar 9, 2026
Maintains: Outperform
Price Target: $11 → $13
Current: $1.88
Upside: +591.49%
Atea Pharmaceuticals
Mar 9, 2026
Maintains: Outperform
Price Target: $6 → $10
Current: $6.10
Upside: +63.93%
Arvinas
Feb 25, 2026
Maintains: Outperform
Price Target: $14 → $19
Current: $12.18
Upside: +55.99%
Aura Biosciences
Nov 26, 2025
Reinstates: Outperform
Price Target: $13
Current: $5.94
Upside: +118.86%
Intellia Therapeutics
Nov 11, 2025
Downgrades: In-Line
Price Target: $17 → $8
Current: $12.76
Upside: -37.30%
ProKidney
Sep 2, 2022
Initiates: Outperform
Price Target: n/a
Current: $2.25
Upside: -
Entrada Therapeutics
Nov 24, 2021
Initiates: Outperform
Price Target: n/a
Current: $12.69
Upside: -
Shattuck Labs
Jan 11, 2021
Initiates: Outperform
Price Target: n/a
Current: $5.99
Upside: -
Nanobiotix
Jan 6, 2021
Initiates: Outperform
Price Target: n/a
Current: $33.07
Upside: -